New atherosclerosis vaccine gives promising results

A new study by researchers in Sweden shows that the immune defense's T cells can attack the "bad" LDL cholesterol and thereby cause an inflammation that leads to atherosclerosis. By producing a vaccine against the T cell receptors, the researchers have managed to inhibit the development of atherosclerosis in animals. The study is expected to be of significance to the treatment of atherosclerosis, heart attack and stroke.

Read the whole article on Science Daily

More from Science Daily